Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay

Introduction Oral sotalol initiation requires a multiple‐day, inpatient admission to monitor for QT prolongation during loading. A 1‐day intravenous (IV) sotalol loading protocol was approved by the United States Food and Drug Administration in March 2020, but limited data on clinical use and admini...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cardiovascular electrophysiology 2023-03, Vol.34 (3), p.502-506
Hauptverfasser:	Liu, Albert Y., Charron, Jessica, Fugaro, Dana, Spoolstra, Scott, Kaplan, Rachel, Lohrmann, Graham, Gao, Xu, Gay, Hawkins, Passman, Rod, Kim, Susan, Lin, Albert C., Chicos, Alexandru, Arora, Rishi, Patil, Kaustubha, Pfenniger, Anna, Knight, Bradley P., Verma, Nishant
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Anti-Arrhythmia Agents - therapeutic use antiarrhythmic drugs Arrhythmias, Cardiac - drug therapy atrial fibrillation atrial flutter Bradycardia Cardiac arrhythmia Feasibility Studies Female Humans Intravenous administration intravenous sotalol Length of Stay Long QT Syndrome - chemically induced Male Middle Aged Patients premature ventricular contractions quality improvement Safety Sotalol - adverse effects Ventricle ventricular tachycardia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!